VACCINATION AGAINST CUTANEOUS LEISHMANIASIS IN MICE USING NONPATHOGENIC CLONED PROMASTIGOTES OF LEISHMANIA MAJOR AND IMPORTANCE OF ROUTE OF INJECTION
Authors:
- 1 April 1984
- journal article
- research article
- Published by Wiley in Immunology & Cell Biology
- Vol. 62 (2) , 145-153
Abstract
Summary: In vaccination studies, mice have been injected by different routes with living promastigotes of nonpathogenic leishmania followed by cutaneous challenge with pathogenic promastigotes. Parasites used for vaccination have been promastigotes of the cloned parasite lines A12 and A52 derived from Leishmania major isolate L137, or long‐term cultured promastigotes of the leishmaniasis recidiva isolate, L32 (L.t.tropica). None of these protozoa causes lesions after cutaneous injection to mice. Disease in previously injected mice has been monitored after cutaneous challenge with promastigotes of a virulent cloned line, V121, derived from isolate L137. Mice used were C57BL/6 (genetically resistant), BALB/c and BALB/c.H‐2b (genetically susceptible) and BALB/c.H‐2k (also genetically susceptible but sometimes less so than BALB/c). C57BL/6 mice were almost completely resistant to subsequent cutaneous disease when challenged after intra‐peritoneal injection of viable nonpathogenic cloned promastigotes. In contrast, BALB/c, BALB/c.H‐2b and BALB/c.H‐2k mice challenged after intravenous or intraperitoneal injection were only protected partially against cutaneous leishmaniasis. These vaccinated mice generally showed persistent low grade cutaneous disease for many months after challenge. High doses of viable L32 promastigotes injected intraperitoneally were also able to induce a degree of resistance to subsequent cutaneous leishmaniasis. Using any protocol, subcutaneous injections have been totally without protective effects as have been killed promastigotes injected by any route to mice. Subcutaneous injections appeal to be ineffective rather than counterproductive in that mice injected by both the intravenous and subcutaneous routes with nonpathogenic living cloned promastigotes resemble mice injected by the intravenous route in their disease status following challengeKeywords
This publication has 11 references indexed in Scilit:
- LEISHMANIA TROPICA MAJOR IN MICE: VACCINATION AGAINST CUTANEOUS LEISHMANIASIS IN MICE OF HIGH GENETIC SUSCEPTIBILITYImmunology & Cell Biology, 1983
- Isolation and characterization of infective and non-infective clones of Leishmania tropicaMolecular and Biochemical Parasitology, 1983
- Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.The Journal of Immunology, 1982
- Stage-specific, strain-specific, and cross-reactive antigens of Leishmania species identified by monoclonal antibodiesInfection and Immunity, 1982
- RESISTANCE TO CUTANEOUS LEISHMANIASIS IN GENETICALLY SUSCEPTIBLE BALB/c MICEImmunology & Cell Biology, 1981
- Monoclonal antibodies that distinguish between New World species of LeishmaniaNature, 1981
- Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tvopica in miceParasite Immunology, 1980
- Leishmania mexicana and Leishmania tropica major: Adoptive transfer of immunity in miceExperimental Parasitology, 1980
- Leishmania mexicana and Leishmania tropica: Cross immunity in C57BL/6 miceExperimental Parasitology, 1979
- MURINE CUTANEOUS LEISHMANIASIS: DISEASE PATTERNS IN INTACT AND NUDE MICE OF VARIOUS GENOTYPES AND EXAMINATION OF SOME DIFFERENCES BETWEEN NORMAL AND INFECTED MACROPHAGESImmunology & Cell Biology, 1979